Andrew Potterton

Company: Ternary Therapeutics

Job title: Chief Technology Officer

Seminars:

Workshop A: Implementing AI & In Silico Technologies to De-Risk the Discovery of Induced Proximity Therapeutics & Accelerate Their Translation 10:00 am - 12:00 pm

The development of induced proximity therapeutics, such as protein degraders and molecular glues, is a rapidly evolving field with significant potential to revolutionise patient lives. While AI can predict surface complementarities, illustrate PK-PD profiles, and design novel compounds, the practical implementation of AI remains complex and costly. Applying AI and molecular dynamics to molecular glue…Read more

day: Workshop A